John Herr, Ph.D. – Scientific Founder
Dr. Herr is the scientific leader for Neoantigenics, chairing the Scientific Advisory Council. Dr. Herr is Professor of Cell Biology, Urology, and Biomedical Engineering at the University of Virginia Medical School, where he is a member of the Cancer Center and serves as Faculty Director of the Lymphocyte Culture Center, which he founded in 1982.
Dr. Herr also founded the Center for Research in Contraceptive and Reproductive Health at the University of Virginia in 1990 and has worked in the field of reproductive biology since 1970 and in cancer biology since 1995. He is the key inventor on the patent applications related to SAS1B. Dr. Herr’s lab has been active in invention having identified or named more than 35 genes in the human genome (e.g., EPAD, CABYR, ACRV1, TSSK, ESP), and has applied for patents on their use as diagnostic or therapeutic targets.
Dr. Herr has a strong interest in technology commercialization and entrepreneurship, founding two previous biotechnology companies: Humagen, an IVF pipette company now a part of Origio, and ContraVac [d.b.a. SpermCheck], developer of the home sperm test SpermCheck Fertility sold nationwide in Walgreens stores. Dr. Herr has served on the Board of Directors of the University of Virginia Licensing & Ventures Group for 15 years.
Cancer Therapy Reinvented | Dr. John C. Herr | TEDxCharlottesville 2014